KWB Wealth Sells 945 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

KWB Wealth lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 22.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,200 shares of the financial services provider’s stock after selling 945 shares during the quarter. KWB Wealth’s holdings in iShares Biotechnology ETF were worth $466,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth $30,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth $36,000. Modus Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth $41,000. Finally, Voisard Asset Management Group Inc. purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth $59,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.8 %

Shares of IBB stock opened at $131.57 on Wednesday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The stock has a fifty day simple moving average of $137.78 and a two-hundred day simple moving average of $141.97.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.